Trial Profile
A 20 Week Double-Blind Randomized Trial of Clomiphene Citrate and Letrozole for the Treatment of Infertility in Women With Polycystic Ovary Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Clomifene (Primary) ; Letrozole (Primary)
- Indications Female infertility; Hyperandrogenism; Polycystic ovary syndrome
- Focus Adverse reactions; Therapeutic Use
- Acronyms PPCOSII
- 11 Apr 2021 Results assessing the associations of Metabolic syndrome with ovulation induction live birth rate and pregnancy complications in obese women with PCOS, and to see if these outcomes differ by specific agent used for ovulation induction, published in the American Journal of Obstetrics and Gynecology
- 31 Aug 2020 Results (N=264), of secondary analysis were participants from PPCOS II and AMIGOS assessing the relationship between high antimullerian hormone (AMH) levels and increased preterm delivery risk in populations of women with polycystic ovary syndrome or unexplained infertility undergoing ovulation induction, published in the Fertility and Sterility
- 05 Aug 2020 Results assessing association of BMI ith reduced AMH in PCOS and ovulatory controls (OVA) and the reduction of AMH, published in the Journal of Clinical Endocrinology and Metabolism.